Navigation Links
Lentigen and UH Case Medical Center Initiate Phase I Trial Using Gene Therapy and Bone Marrow Stem Cells in the Treatment of Brain Cancer
Date:11/14/2011

CLEVELAND and GAITHERSBURG, Md., Nov. 14, 2011 /PRNewswire/ -- University Hospitals (UH) Case Medical Center, Case Western Reserve University School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells (HSCs) from the dose limiting toxicity of chemotherapy with Temodar.  

Approximately 17,000 Americans are diagnosed with glioblastoma every year and only two percent of them survive longer than five years -- even with aggressive treatment.  Glioblastoma (GBM) treatment generally begins with a surgical resection, followed by radiation therapy and then chemotherapy to destroy any remaining cancer cells.  Temodar (temozolomide, Merck and Co., Inc.) is a standard treatment of glioblastoma, but dose-limiting bone marrow toxicity often accompanies such therapy.

In this first-of-its-kind study, researchers are investigating if LG631 can potentially improve tolerance and effectiveness of chemotherapy for GBM by preventing damage to bone marrow. The study will evaluate the safety of this treatment and its potential to enhance current GBM treatments.

For this study, HSCs will be isolated from participating patients, transduced with LG631, an altered human-Methylguanine Methyltransferase (MGMT) gene to make them resistant to Temodar, and then infused back into the patient.  The MGMT gene has been shown to repair damaged DNA. The specially designed Lentiviral vector (LG631) will be used to deliver the gene specifically to bone marrow stem cells that are susceptible to damage by drugs commonly used to treat cancer, thereby enabling patients to receive higher doses of Temodar with less severe side effects.

"Glioblastoma is a devastating disease and many patients do not benefit from standard therapy," notes Dr. Andrew Sloan, Director of the Brain Tumor and Neuro-Oncology Center, UH Case Medical Center and Associate P
'/>"/>

SOURCE Lentigen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine
2. University Hospitals Case Medical Center Researchers Search for Mysteries of Dystonia With Advanced Brain Imaging
3. Dehaier Medical to Participate in MEDICA 2011 in Dusseldorf, Germany from November 16-19, 2011
4. Dehaier Medical Announces Record Third Quarter 2011 Financial Results
5. OncoSec to Present at Medical Device Investor Forum
6. Winner Medical Reports Selected Preliminary Unaudited Fourth Quarter Fiscal 2011 Results
7. Cheyenne Regional Medical Center Announces New Air Ambulance Service Partnership with HealthONEs AirLife Denver
8. Panasonic Unveils Relationship with Cenegenics Medical Institute Featuring CardioHealth Station
9. Winner Medical to Participate in Upcoming Investor Conferences in China
10. Shands Jacksonville Medical Center Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
11. Medical Oncology Association of Southern California, Cardinal Health Specialty Solutions Collaborate With Payors to Improve Quality, Costs, Accessibility of Cancer Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... and SHANGHAI , Sept. 22, ... a global knowledge leader in healthcare technology, media ... support healthcare innovation in China ... health technologies. Continua and BHG announced this new ... held this week in Washington, DC ...
(Date:9/22/2014)... 2014 Persistence Market Research ( ... Study on Ophthalmic Devices: Asia ... market was valued at USD 29,171.5 million in 2014 and ... from 2014 to 2020, to reach an estimated value ... the full Global Market Study on Ophthalmic Devices:  Asia ...
(Date:9/22/2014)... 2014  Aethlon Medical, Inc. (OTCQB: AEMD), the ... infectious disease, cancer and other life-threatening conditions, disclosed ... (DARPA) has informed the Company that it plans ... four of a five-year $5.9 million contract that ... under DARPA,s Dialysis-Like Therapeutics (DLT) program. ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 2Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 3Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 4Global Ophthalmic Devices Market will Reach $2,685.1 Million in 2020: Persistence Market Research 5Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4
... SILVER SPRING, Md., March 25, 2011 The U.S. Food ... patients with late-stage (metastatic) melanoma, the most dangerous type ... ) Melanoma is the leading cause ... cases of melanoma were diagnosed in the United States ...
... CoreLab Partners, Inc , the global entity resulting ... is set to attend and actively participate in several ... two weeks. "The legacy of our organization ... physicians, scientists and operational personnel have provided to the ...
Cached Medicine Technology:FDA Approves New Treatment for a Type of Late-Stage Skin Cancer 2FDA Approves New Treatment for a Type of Late-Stage Skin Cancer 3CoreLab Partners Collaborates at Worldwide Industry Conferences 2
(Date:9/22/2014)... New Port Richey, FL (PRWEB) September 22, 2014 ... article, “medical marijuana dispensaries in [Berkeley] will be required ... to low-income residents” beginning in August, 2015. (1) ... Florida-based detox centers serving high-dosage drug abuse patients, ... only further contribute to the nation’s already rampant drug ...
(Date:9/22/2014)... Texas (PRWEB) September 22, 2014 ... and treatment, will work with companies to help employees ... the development of diabetes as part of a collaboration ... Diabetes @ Work initiative. , PreDiabetes Centers Medical ... Department of Transportation in Austin on Tuesday, October 21st ...
(Date:9/22/2014)... Health 2.0 8th Annual Fall Conference ... a leading provider of intelligent health information and ... to harness the power of structured and ... The new big data analytics platform leverages the ... language processing (NLP) technologies and semantic analysis to ...
(Date:9/22/2014)... HealthDay Reporter FRIDAY, Sept. ... people with type 2 diabetes found that intensively lowering ... attacks, strokes and deaths. But intensive blood sugar control ... the study, investigators followed nearly 8,500 participants of a ... pressure and blood sugar levels strictly controlled, while others ...
(Date:9/22/2014)... Caliper, an internationally recognized talent management consulting firm ... with the When Work Works Award for making work-life ... to increase business and employee success. , Caliper’s ... work and family commitments effectively. As a result, turnover ... high. , “At Caliper, our primary mission is ...
Breaking Medicine News(10 mins):Health News:New York Times Questions Gratuitous Medical Marijuana in California—Novus Medical Detox Says Increased Availability Encourages Overuse, Advises Against Movement 2Health News:New York Times Questions Gratuitous Medical Marijuana in California—Novus Medical Detox Says Increased Availability Encourages Overuse, Advises Against Movement 3Health News:New York Times Questions Gratuitous Medical Marijuana in California—Novus Medical Detox Says Increased Availability Encourages Overuse, Advises Against Movement 4Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 3Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 2Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 3Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 4Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 5Health News:Tight Blood Sugar Control Doesn't Prevent Strokes in Diabetics: Study 2Health News:Tight Blood Sugar Control Doesn't Prevent Strokes in Diabetics: Study 3Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 2Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 3
... could lead to new treatments, researchers say , , WEDNESDAY, ... immune cells exhausted from fighting HIV infection has been ... that a molecule called Tim-3 is present at high ... combating HIV, the virus that causes AIDS. Blocking the ...
... physicians and caregivers to improve cultural sensitivity and ... these women to get mammograms that could save ... the Journal of General Internal Medicine. ... perceive they are being treated with disrespect and ...
... Latest Release Includes Enhanced Scheduling, Financial and ... Social Workers, GREAT RIVER, N.Y., Nov. ... of enterprise-wide software and services for health ... availability,release of version 7.5 of Helper, the ...
... bring enough benefit to offset expense , , WEDNESDAY, Nov. ... may not justify the marginal benefit, a new study ... (AHA) annual scientific sessions in New Orleans found that ... in some patients but "at a cost generally considered ...
... Demonstrate Best Strategic Use of Mergers ... ... http://www.thedeal.com ) magazine has named Abbott,( http://www.abbott.com )as the healthcare sector ... Abbott for the,most effective strategic use of acquisitions and divestitures., ...
... of Rutgers University is one of 10 2008 Pew ... Pew Charitable Trusts. Launched in 1991, the Pew Latin ... trained Latin American scientists who show potential for stimulating ... as well as fostering collaboration between scientists in Latin ...
Cached Medicine News:Health News:Way to Rescue Tired Immune Cells Fighting HIV Found 2Health News:Fear, misconceptions about screenings keep many African-Americans from getting mammograms 2Health News:Fear, misconceptions about screenings keep many African-Americans from getting mammograms 3Health News:Netsmart Technologies Releases Version 7.5 of Helper(TM) Practice Management Software 2Health News:Netsmart Technologies Releases Version 7.5 of Helper(TM) Practice Management Software 3Health News:Angioplasty Not Always Worth the Price 2Health News:Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers 2Health News:Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers 3
... for catheter or instrument introduction. The ... be peeled away and removed. The ... instrument to be introduced should be ... the sheath. Supplied sterile in peel-open ...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Used when establishing a percutaneous tract for nephrostomy drainage. The guide has a stiff shaft and a gradual transition to a very flexible distal tip. Supplied sterile in peel-open packages. Inten...
Medicine Products: